ARTICLE | Company News
Toctino recommended for approval
August 1, 2008 1:46 AM UTC
Basilea (SWX:BSLN) said its oral Toctino alitretinoin to treat severe refractory chronic hand eczema (CHE) has been recommended for approval by 11 EU member states under the decentralized procedure. T...